RENEWVAX LIMITED

Active Liverpool

Research and experimental development on biotechnology

2 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
R

RENEWVAX LIMITED

Research and experimental development on biotechnology

Founded 28 Jan 2022 Active Liverpool, England 2 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

ZAPVAX LIMITED 28 Jan 2022 — 15 Jun 2022
Accounts Due 30 Sept 2026 5 months remaining
Confirmation Submitted 29 Jan 2026 Next due 10 Feb 2027 9 months remaining
Net assets £160K £508K 2024 year on year
Total assets £206K £123K 2024 year on year
Total Liabilities £46K £385K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Liverpool Science Park 131 Mount Pleasant Liverpool L3 5TF England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for RENEWVAX LIMITED (13878327), an active life sciences and medical technology company based in Liverpool, England. Incorporated 28 Jan 2022. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2022–2024)

Cash in Bank

£175.60k

Increased by £136.25k (+346%)

Net Assets

£159.63k

Increased by £508.21k (+146%)

Total Liabilities

£46.13k

Decreased by £385.22k (-89%)

Turnover

N/A

Employees

2

Decreased by 1 (-33%)

Debt Ratio

22%

Decreased by 499 (-96%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (2)

Investor NameInvestor SinceParticipating Rounds
Investor 1Nov 2022Seed
Investor 2Nov 2022Seed

Share Capital

Share Capital

Share allotments and capital structure

7 Allotments 496,450 Shares £511k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
24 Dec 202562,500£125k£2
4 Dec 202550,000£100k£2
2 May 202575,000£150k£2
5 Mar 2025240,500£24.05£24.05
5 Mar 202562,500£125k£125k

Officers

Officers

2 active 1 resigned
Status
Roger BickerstaffSecretaryUnknownUnknown28 Jan 2022Active
Thorn, Simon WilliamSecretaryUnknownUnknown7 Apr 2026Active

Shareholders

Shareholders (11)

University Of Liverpool
21.9%
275,000
Marie O'brien
19.2%
240,500

Persons with Significant Control

Persons with Significant Control (2)

2 Active 1 Ceased

University Of Liverpool

United Kingdom

Active
Notified 28 Jan 2022
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors

Aras Kadioglu

British

Active
Notified 9 May 2022
Residence England
DOB November 1968
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Marie O'brien

Ceased 18 Oct 2024

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
22 Apr 2026OfficersAppointment of Mr Simon William Thorn as director on 2026-04-07
29 Jan 2026Confirmation StatementConfirmation statement made on 2026-01-27 with updates
27 Jan 2026OfficersTermination of Roger Bickerstaff as director on 2026-01-26
25 Jan 2026MiscellaneousReplacement filing of SH01 - 24/12/25 Statement of Capital gbp 125.50
21 Jan 2026CapitalAllotment of shares (GBP 120.5) on 2025-12-04
22 Apr 2026 Officers

Appointment of Mr Simon William Thorn as director on 2026-04-07

29 Jan 2026 Confirmation Statement

Confirmation statement made on 2026-01-27 with updates

27 Jan 2026 Officers

Termination of Roger Bickerstaff as director on 2026-01-26

25 Jan 2026 Miscellaneous

Replacement filing of SH01 - 24/12/25 Statement of Capital gbp 125.50

21 Jan 2026 Capital

Allotment of shares (GBP 120.5) on 2025-12-04

Recent Activity

Latest Activity

Appointment of Mr Simon William Thorn as director on 2026-04-07

3 days ago on 22 Apr 2026

Confirmation statement made on 2026-01-27 with updates

2 months ago on 29 Jan 2026

Termination of Roger Bickerstaff as director on 2026-01-26

2 months ago on 27 Jan 2026

Replacement filing of SH01 - 24/12/25 Statement of Capital gbp 125.50

3 months ago on 25 Jan 2026

Allotment of shares (GBP 120.5) on 2025-12-04

3 months ago on 21 Jan 2026